These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20848055)

  • 1. Elevated serum CA 19-9 in association with Hashimoto thyroiditis.
    Jamaludin AZ; Metassan MM; Zainal-Abidin Z; Chong VH
    Singapore Med J; 2010 Aug; 51(8):e143-5. PubMed ID: 20848055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroxine replacement dose in patients with Hashimoto disease: a potential role for interleukin-6.
    Papanas N; Papazoglou D; Papatheodorou K; Antonoglou C; Kotsiou S; Maltezos E
    Cytokine; 2006 Aug; 35(3-4):166-70. PubMed ID: 16949834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [47-year-old man with fatigue and hair loss].
    Janssen OE
    Dtsch Med Wochenschr; 2011 Mar; 136(11):523-4. PubMed ID: 21387210
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
    Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
    J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of elevated levels of serum CA 19-9.
    Pavai S; Yap SF
    Med J Malaysia; 2003 Dec; 58(5):667-72. PubMed ID: 15190651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hashimoto thyreoiditis].
    Gärtner R
    MMW Fortschr Med; 2009 Feb; 151(6):45. PubMed ID: 19432252
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.
    Mann DV; Edwards R; Ho S; Lau WY; Glazer G
    Eur J Surg Oncol; 2000 Aug; 26(5):474-9. PubMed ID: 11016469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hydronephrosis with high level of serum Span-1 antigen and CA19-9].
    Kondoh K; Noguchi S; Shuin T; Masuda M; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Jan; 42(1):51-3. PubMed ID: 8686585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Episodes of thyrotoxicosis in Hashimoto's thyroiditis.
    Gonzalez Gonzalez A; Recio Cordov JM; Rodriguez-García JL; Velasco Romero AM; Rubio Herrera MA
    Minerva Endocrinol; 2010 Mar; 35(1):35-6. PubMed ID: 20386526
    [No Abstract]   [Full Text] [Related]  

  • 11. Hashimoto thyroiditis with crystalloid formation.
    Roychowdhury M; Pambuccian SE
    Diagn Cytopathol; 2011 Dec; 39(12):909-11. PubMed ID: 20891006
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy.
    Cecchi E; Lapi F; Vannacci A; Banchelli G; Mazzei T; Mugelli A
    J Clin Pharm Ther; 2009 Feb; 34(1):129-32. PubMed ID: 19125912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.
    Akinci B; Comlekci A; Yener S; Bayraktar F; Demir T; Ozcan MA; Yuksel F; Yesil S
    Arch Med Res; 2008 May; 39(4):397-401. PubMed ID: 18375250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High levels of carcinoembryonic antigen in a woman with hypothyroidism].
    van Mil AH; Beijer C; Jonkers GJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1071-4. PubMed ID: 11414169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal CA 19-9 levels in Hashimoto's thyroiditis.
    Sezer K; Cakal E; Ozkaya M; Yaman E; Akbay E
    Asian Pac J Cancer Prev; 2009; 10(2):315-8. PubMed ID: 19537903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hashimoto encephalopathy responding to risperidone.
    Bismilla Z; Sell E; Donner E
    J Child Neurol; 2007 Jul; 22(7):855-7. PubMed ID: 17715278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of lumbar intradural and epidural abscesses presenting with elevated serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9)].
    Koide R; Taniguchi M; Ueki Y; Isozaki E; Hayashi H
    No To Shinkei; 2003 May; 55(5):443-7. PubMed ID: 12833889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradox of rising thyroid stimulating hormone despite increasing thyroxine dose in hypothyroidism and the association with nephrotic syndrome.
    Yeoh EC; Claude JR; Rajasoorya C
    Nephrology (Carlton); 2013 Sep; 18(9):647-8. PubMed ID: 23980816
    [No Abstract]   [Full Text] [Related]  

  • 20. Sweet syndrome associated with Hashimoto thyroiditis.
    Medeiros S; Santos R; Carneiro V; Estrela F
    Dermatol Online J; 2008 Sep; 14(9):10. PubMed ID: 19061592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.